Ep:385 REPLACE STATINS WITH THIS FDA-APPROVED PLAQUE STABILIZER

Dr. Robert Cywes the #CarbAddictionDoc
16 Jul 202420:16

Summary

TLDRDr. Rob Cvis discusses the underutilized drug colchicine as a powerful anti-inflammatory for cardiovascular disease, which the FDA has approved to be more effective than statins in reducing risk. He emphasizes its benefits for secondary prevention, particularly in patients with high CRP levels, and suggests it as a safer and cost-effective alternative to statins, potentially in combination with low-dose aspirin, for reducing inflammation and vascular events.

Takeaways

  • 👨‍⚕️ Dr. Rob is discussing the underutilization of colchicine compared to statins for cardiovascular disease, despite its proven effectiveness.
  • 💊 Colchicine, known for treating gout, has been FDA-approved for its higher risk reduction in cardiovascular disease compared to statins.
  • 🧬 Colchicine's history dates back to 1500 BC, originally used for joint inflammation and is derived from a plant.
  • 🔍 The drug works as a powerful anti-inflammatory, which is crucial in addressing the root cause of cardiovascular issues rather than just the symptoms.
  • 💡 Dr. David Nebert, an electrophysiology cardiologist, highlighted the benefits of colchicine for secondary prevention in patients with existing cardiovascular disease.
  • 📉 High-sensitivity C-reactive protein (hsCRP) levels are a significant indicator of inflammation and cardiovascular risk, where colchicine can be beneficial.
  • 💲 The low cost and less aggressive marketing of colchicine may contribute to its lesser-known status compared to statins.
  • 🛑 For patients with a history of heart attack, stroke, or significant plaque burden, colchicine should be considered as a serious medication option.
  • 🚫 The script suggests that colchicine might be a replacement for statins rather than used in conjunction due to its anti-inflammatory properties.
  • 📚 A study published in the Journal of the American College of Cardiology emphasizes the predictive power of hsCRP over LDL cholesterol for cardiovascular events.
  • 📉 FDA approval in June 2023 recognized colchicine's role in reducing the risk of major adverse cardiovascular events, including in patients with atrial fibrillation.

Q & A

  • Who is Dr. Rob Cvis and what is his area of expertise?

    -Dr. Rob Cvis is a specialist in lipidology and cardiology, often referred to as the 'carb addiction Doc'. He focuses on the effects of carbohydrates on health and the role of various treatments in managing cardiovascular diseases.

  • What is the main point of the video regarding the use of Statins by cardiologists?

    -The video suggests that cardiologists often insist on prescribing Statins for cardiovascular disease, despite the availability of other drugs like colchicine that may be more effective at reducing the risk of cardiovascular events.

  • What is colchicine and how is it typically used?

    -Colchicine is a drug that has been used for centuries and is typically prescribed for conditions like gout and inflammation. It is derived from a plant and was known as early as 1500 BC.

  • Why does Dr. Cvis believe colchicine is more effective than Statins for certain cardiovascular conditions?

    -Dr. Cvis believes colchicine is more effective because it is a powerful anti-inflammatory that significantly reduces vascular inflammation, which is a primary factor in cardiovascular diseases. The FDA has approved colchicine for reducing coronary artery disease risk at a level greater than Statins.

  • What is the role of inflammation in cardiovascular disease as discussed in the video?

    -Inflammation is presented as a key factor in cardiovascular disease. It is suggested that by reducing inflammation, particularly in the blood vessels, the risk of cardiovascular events can be significantly lowered.

  • How does colchicine work in relation to atherosclerotic cardiovascular disease?

    -Colchicine works by reducing the activation of white blood cells, decreasing their aggressive function, and reducing their adhesion to plaques, which are a major component of atherosclerosis.

  • What is the significance of C-reactive protein (CRP) in the context of the video?

    -CRP is highlighted as a marker of inflammation that is more predictive of cardiovascular death than LDL cholesterol. Elevated CRP levels are an indication for considering colchicine as a treatment option.

  • What is the FDA's stance on the use of colchicine for cardiovascular disease?

    -The FDA has approved the use of low-dose colchicine to reduce the risk of major adverse cardiovascular events, including heart attack, stroke, and cardiovascular death in patients with established atherosclerotic disease.

  • Why does Dr. Cvis suggest that colchicine could be a better alternative to Statins for some patients?

    -Dr. Cvis suggests that colchicine could be a better alternative due to its anti-inflammatory properties, its effectiveness in reducing cardiovascular risk, and its lower cost compared to Statins.

  • What is the recommended dosage of colchicine according to Dr. David Nebert, as mentioned in the video?

    -Dr. David Nebert recommends a low dose of 0.5 mg of colchicine for patients with elevated CRP levels and a history of cardiovascular disease, as part of a secondary prevention strategy.

  • How does Dr. Cvis view the combination of low-dose aspirin and colchicine for certain patients?

    -Dr. Cvis sees the combination of low-dose aspirin and colchicine as a potentially healthier and more effective alternative to Statins, especially for patients with a history of cardiovascular events and ongoing inflammation.

Outlines

00:00

🤔 The Overlooked Superiority of Colchicine Over Statins

Dr. Rob Cvis discusses the puzzling preference of cardiologists for prescribing statins despite evidence suggesting that colchicine is more effective in reducing cardiovascular disease. He points out that colchicine, known for its use in treating gout, has been FDA-approved for its high risk reduction in atherosclerotic cardiovascular disease, a fact often overlooked. Dr. David Nebert, an electrophysiology cardiologist, is credited for bringing this to light. The video emphasizes the need to consider colchicine for its anti-inflammatory properties, especially in patients with a history of heart attack, stroke, or elevated C-reactive protein (CRP) levels, indicating inflammation.

05:02

🛡️ Colchicine as a Powerful Anti-Inflammatory for Secondary Prevention

This paragraph delves into the anti-inflammatory benefits of colchicine, highlighting its effectiveness in reducing vascular inflammation, which is superior to that of statins. Dr. Cvis suggests that colchicine should be considered for secondary prevention in patients with significant plaque burden or a history of cardiovascular events. The paragraph also touches on colchicine's role in reducing amyloid protein synthesis, associated with conditions like Alzheimer's disease, and its potential in managing atrial fibrillation by decreasing inflammation in heart cells. The importance of using the right dosage of colchicine to avoid toxicity is stressed, along with its historical use since 1500 BC for joint inflammation.

10:03

🧬 Colchicine's Mechanism of Action and Its Impact on Inflammation

The speaker explains the mechanism by which colchicine operates, focusing on its ability to reduce the activation and adhesion of white blood cells to plaque, a process fundamental to the development of atherosclerosis. Aspirin is mentioned as a complement to colchicine, with the dual therapy potentially offering significant benefits in managing cardiovascular disease by addressing both clot formation and inflammation. The paragraph also discusses the correlation between high uric acid levels, a risk factor for gout and kidney stones, and cardiovascular disease, suggesting that colchicine's benefits extend to these conditions as well.

15:03

💊 Dosage Considerations and the Role of Colchicine in Patient Management

Dr. Cvis shares insights on the dosing of colchicine, advocating for a low-dose approach to minimize toxicity risks while maximizing anti-inflammatory benefits. He discusses the cost-effectiveness of colchicine compared to statins and emphasizes the importance of patient knowledge in making informed decisions about their treatment. The video also presents a case study of a patient with a high calcium score and stroke history, suggesting that colchicine could have been a beneficial addition to the patient's regimen. Dr. David Nebert's dosing strategy for patients with elevated CRP is introduced, recommending an initial dose of 0.5 mg to 0.6 mg of colchicine.

20:05

📚 FDA Approval and the Future of Colchicine in Cardiovascular Disease Management

The final paragraph summarizes the FDA's approval of low-dose colchicine for reducing the risk of cardiovascular events in patients with established atherosclerotic disease or multiple risk factors. It contrasts the traditional focus on lipids and LDL cholesterol with the emerging understanding of inflammation as a key driver of cardiovascular disease. The paragraph cites a study from the Journal of the American College of Cardiology that positions high-sensitivity CRP as a stronger predictor of cardiovascular death than LDL cholesterol. It concludes with a strong personal endorsement from Dr. Cvis for considering colchicine as a replacement for statins in appropriate cases.

👋 Closing Remarks and Call to Support

In the closing paragraph, Dr. Cvis invites viewers to support the channel financially if they have found the information valuable, suggesting a contribution to the PayPal account mentioned. This paragraph serves as a sign-off, indicating the end of the video content.

Mindmap

Keywords

💡Statin

Statins are a class of drugs commonly prescribed to lower cholesterol levels, particularly LDL cholesterol, in order to reduce the risk of cardiovascular diseases. In the video, Dr. Rob CVIS discusses the common practice of cardiologists recommending statins as a first line of treatment without considering other potentially more effective options.

💡Colchicine

Colchicine is a medication derived from a plant and has been used since ancient times for treating gout and reducing inflammation. The video emphasizes that colchicine has been shown to be more effective in reducing cardiovascular risk than statins, but it is less commonly known or prescribed for this purpose.

💡Cardiologist

A cardiologist is a medical professional specializing in the diagnosis and treatment of heart conditions. The video script mentions that cardiologists often insist on prescribing statins, despite the existence of alternative treatments with potentially greater benefits, such as colchicine.

💡Inflammation

Inflammation is part of the body's immune response to harmful stimuli but can also contribute to the development of chronic diseases. In the video, Dr. Rob CVIS argues that inflammation is a key factor in cardiovascular disease and that colchicine is a powerful anti-inflammatory that can be more effective than statins in managing this aspect of the disease.

💡Atherosclerotic cardiovascular disease

Atherosclerotic cardiovascular disease refers to conditions caused by the buildup of plaque in the arteries, which can restrict blood flow and lead to heart attacks or strokes. The video highlights that colchicine has been approved by the FDA for reducing the risk of this type of disease more effectively than statins.

💡CRP (C-reactive protein)

C-reactive protein is a blood test marker used to measure inflammation levels in the body. The video script discusses the significance of CRP levels in determining the presence of inflammation and the potential benefits of using colchicine in patients with elevated CRP levels.

💡Secondary prevention

Secondary prevention refers to measures taken to prevent a second occurrence of a disease, especially after a first event like a heart attack or stroke. The video suggests that colchicine should be considered for secondary prevention in patients with established cardiovascular disease.

💡Uric acid

Uric acid is a waste product that can lead to gout and kidney stones when present in high levels. The video mentions that colchicine is commonly used to treat conditions related to elevated uric acid, such as gout, and that high uric acid levels are also associated with cardiovascular disease.

💡Aspirin

Aspirin is a medication often used for its anti-inflammatory and antiplatelet effects, which can help prevent blood clots. The video proposes a combination of low-dose aspirin and colchicine as a potentially more effective approach than statins for certain patients with cardiovascular disease.

💡Atrial fibrillation

Atrial fibrillation is a type of irregular heartbeat that can lead to blood clots, stroke, or heart failure. The video script indicates that colchicine may help reduce inflammation associated with atrial fibrillation and potentially decrease the risk of this condition.

💡Alzheimer's disease

Alzheimer's disease is a progressive neurological disorder that causes memory loss and cognitive decline. The video discusses the role of inflammation in Alzheimer's and suggests that colchicine, by reducing inflammation, may have a beneficial effect on the disease, unlike some drugs that directly target amyloid protein.

Highlights

Dr. Rob explains the common insistence on prescribing Statins by cardiologists despite their awareness of more effective alternatives for cardiovascular disease reduction.

Introduction of Colchicine, a drug known for its use in Gout but also recognized by the FDA for its higher risk reduction in cardiovascular disease compared to Statins.

Colchicine's history dating back to 1500 BC and its traditional use for joint inflammation.

The anti-inflammatory properties of Colchicine and its effectiveness in reducing vascular inflammation more than Statins.

The FDA's approval of Colchicine for reducing coronary artery vascular risk at a level greater than Statins.

The economic factors influencing the prescription of Statins over Colchicine, despite the latter's proven benefits.

Colchicine's mechanism of action in reducing inflammation and its dosage considerations to avoid toxicity.

The role of Colchicine in reducing Amalo protein synthesis, associated with Alzheimer's disease.

Colchicine's potential in reducing atrial fibrillation by decreasing inflammation in pulmonary veins.

The synergistic effect of combining low-dose aspirin with Colchicine for secondary prevention of cardiovascular events.

The importance of considering inflammation as the primary cause of cardiovascular disease rather than focusing solely on lipids and LDL cholesterol.

The benefits of Colchicine in reducing the risk of a second cardiovascular event, particularly in patients with a history of heart attack or stroke.

The paper from the Journal of the American College of Cardiology highlighting the predictive power of inflammation over LDL in cardiovascular mortality.

Dr. Rob's opinion on using Colchicine as a replacement for Statins in certain patient populations.

The FDA's approval in June 2023 for the use of low-dose Colchicine to reduce the risk of myocardial infarction, stroke, and cardiovascular death.

The potential of Colchicine to be a cost-effective and safer alternative to Statins for patients with established cardiovascular disease.

The strategy of adjusting Colchicine dosage based on CRP levels and the importance of patient compliance.

Transcripts

play00:00

hi folks this is Dr Rob cvis and I am

play00:02

the carb addiction Doc and is the final

play00:05

in the series of lipidology Cardiology

play00:08

Statin type uh drugs and Statin thinking

play00:13

um one of this is the final video and

play00:16

one of the things that perplexes me

play00:18

always is when you see a cardiologist

play00:21

before you even walk in the door you

play00:23

might be a delivery person but they're

play00:24

talking to you about you need to be on a

play00:26

Statin and there's nothing that can

play00:28

dissuade them from that narrative and

play00:30

yet there are several things that they

play00:33

know about that they absolutely know

play00:35

about it's in their literature FDA

play00:37

approved where the drugs are far more

play00:42

effective at reducing cardiovascular

play00:45

disease than statens and yet they will

play00:47

insist on a stattin and most of them

play00:48

have never ever mentioned this word so

play00:52

there's a drug out there called culture

play00:54

scene some of you may know it if you've

play00:56

got Gout you've probably heard of

play00:57

culture scene but most of you there's

play01:00

nobody that's watching these videos that

play01:01

doesn't know the word Staten and I bet

play01:04

you very very few of you know the word

play01:06

culture scene so uh the FDA a few years

play01:09

ago proved culture

play01:12

scene as a very powerful

play01:15

drug with a much higher risk reduction

play01:18

than

play01:20

stattin for cardiovascular disease for

play01:23

atherosclerotic cardiovascular disease

play01:26

and um you've seen this guy on this

play01:28

channel I've got a a friend and a

play01:31

patient by the name of Dr David nebert

play01:34

who is a electrophysiology cardiologist

play01:36

he's a cardiologist and he brought this

play01:38

to my attention I knew about and I use

play01:41

culture scene for my Gout patients I use

play01:43

it for inflammation but I haven't looked

play01:46

at the association of culture scene and

play01:49

risk reduction for cardiovascular

play01:50

disease and yes the you want to reduce

play01:53

the inflammatory response you want to

play01:56

reduce the cause of the inflammation but

play01:58

early on as you responding to that this

play02:01

inflammation why not let's consider and

play02:03

let's talk about culture scene and what

play02:05

it does and what the risks and benefits

play02:08

are so in patients on a standard

play02:11

American diet in patients with a

play02:13

significant you've had a CAC score now

play02:16

you've got pla in your you know you've

play02:18

got pla in your blood vessels or you've

play02:20

had a heart attack you've had a stroke

play02:21

you've had an event and we

play02:23

call the intervention secondary

play02:26

prevention so you've had an event now

play02:28

we've got to reduce

play02:30

the risk of a second intervention uh of

play02:32

a second event and the FDA as I said has

play02:37

approved C culture scene to reduce

play02:40

coronary artery vascular risk CBD

play02:43

risk at a level that is far greater than

play02:47

Statin so if you have positive

play02:51

cardiovascular disease and measurable

play02:53

inflammation and this blood work that we

play02:55

do high fertin or a highly selective CRP

play02:59

C reactive protein above two now ideally

play03:03

I want that below three which is an

play03:06

anti-inflammatory thing but if youve got

play03:07

ongoing

play03:08

inflammation and we can measure that

play03:10

with white cell count we can measure it

play03:12

with um uh fertin CRP is the one that

play03:15

the cardiologists use and I think it's a

play03:17

valid valid number if that's elevated

play03:19

and you have plaque culture scene should

play03:22

be a seriously considered medication for

play03:25

a while to reduce that

play03:28

inflammation and we're talking about

play03:31

something that is secret why because

play03:32

culture scene doesn't cost very much

play03:34

money doesn't make a lot of money for

play03:35

the insurance companies it is ranked as

play03:38

the

play03:39

184th most commonly prescribed drug

play03:42

stattin being right up there is number

play03:44

one or two I think that one through cuz

play03:47

money money and I know I'm not that jist

play03:51

conspiracy theorist but that is a direct

play03:54

correlation especially if you

play03:56

consider a significantly increased risk

play03:59

production versus stens so what is

play04:02

culture scene culture scene actually

play04:05

comes from a plant and we've known about

play04:06

it since 1500

play04:10

ad okay sorry uh 1500 BC I'm sorry BC

play04:15

before

play04:16

Christ okay 1500 years before Christ uh

play04:19

folks ate this for joint inflammation

play04:21

it's one of the crocus plants they used

play04:23

to consume it for joint

play04:25

inflammation so what culture scene does

play04:28

is culture scene is a powerful

play04:31

anti-inflammatory we go into the

play04:32

mechanism and the most common use of

play04:34

culture scene right now is for gout for

play04:36

elevated uric acid so if you have an

play04:38

attack of gout affects your fingers

play04:41

affects your toes big toes is the most

play04:42

common one or if you have kidney stones

play04:45

a lot of doctors like myself will use a

play04:48

short 2 or 3 Day course of of culture

play04:51

scine to reduce the inflammation from

play04:54

gut but uric acid uh which is a product

play04:58

of fructose consumption a carbohydrate

play05:01

um also results in a risk of gout and a

play05:04

risk of kidney stones sodium Uric urate

play05:07

Stones um and alopurinol is one of the

play05:10

drugs that dumbs that down so alopurinol

play05:12

is this is the preventive why do we use

play05:14

culture scine that often as prevention

play05:16

although I do because its drug range its

play05:18

dosage range has to be very tight it can

play05:21

have devastating effects when it's

play05:23

overdosed so please the more is better

play05:26

population out there the more is better

play05:28

a little bit work going to take more

play05:30

please do not do that if you're going to

play05:32

consider culture scene because more can

play05:34

be very toxic at a high level range but

play05:36

if you're in the 0.5 to point6 range and

play05:38

I'm going to at the end of this I'm

play05:39

going to use Dr neighbor it's dosing uh

play05:42

pattern uh to talk about it but what

play05:44

culturein does is it prevents

play05:47

inflammation of the joints and so

play05:50

culture scine is a very powerful

play05:53

anti-inflammatory primarily associated

play05:55

with goat use uh with gout goat with

play05:57

gout use however

play06:00

vascular inflammation and a reduction in

play06:03

vascular inflammation is its primary

play06:06

effect so culture scene significantly

play06:09

reduces the vascular inflammatory

play06:13

response far better than Statin and it

play06:17

it should be a go-to

play06:20

drug for secondary prevention that is

play06:23

the most important consideration so if

play06:26

you've got a significant plaque burden

play06:28

if you've had an event to stroke or a

play06:29

heart attack culine should be a very

play06:32

serious drug at the top of that list

play06:35

until we get rid of the

play06:37

inflammation maybe together with with an

play06:39

aspirin and we have to shift our

play06:43

thinking of cardiovascular disease away

play06:45

from lipids and away from LDL and

play06:47

cholesterol toward inflammation once you

play06:50

consider inflammation as the cause of

play06:52

this disease then culture seene Falls

play06:54

very neatly into place and in my opinion

play06:59

and I'm going to modify my management

play07:01

the combination for certain patients

play07:03

with high risk a combination of a lowd

play07:06

dose aspirin as well as culture scine at

play07:09

low dose is the healthiest combination

play07:13

especially if you've had a stroke or

play07:14

heart attack now one of the interesting

play07:17

things is that ccine also reduces amalo

play07:21

protein synthesis and for those of you

play07:24

who don't know amalo amalo is a protein

play07:27

replacement within organs when cells of

play07:31

those organs die so we see amalo in the

play07:33

pancreas and people with diabetes type 1

play07:35

diabetes but the biggest biggest

play07:39

biggest replacement tissue replacement

play07:42

by amalloy

play07:44

occurs in the brain and we call that

play07:47

disease

play07:48

Alzheimer's and so many experimental

play07:51

companies are are are uh producing drugs

play07:55

that block block protein synthesis that

play07:58

block am that block amalo protein

play08:00

synthesis and the FDA has even approved

play08:02

some of these pathetically weak drugs

play08:05

you've heard about them Alzheimer's

play08:07

because they're going to make money but

play08:08

they don't affect Alzheimer's because

play08:10

Alzheimer's is an inflammatory

play08:12

condition and the amalo is there to

play08:15

replace the death of the brain cells and

play08:18

what culine does is it's associate with

play08:21

a reduction in amalo but it doesn't

play08:23

directly reduce amalo it reduces the

play08:25

inflammation so there are lower levels

play08:27

of amalo

play08:30

but what they do the farmer companies

play08:32

they directly treat the amalo block the

play08:35

production of amalo but that's not

play08:37

fixing the inflammation cine

play08:40

does cine is also so we've talked about

play08:43

it as inflammation in the blood vessels

play08:46

the plumbing to reduce aerosis but

play08:49

culture scene also works very

play08:51

effectively and attention diabetics type

play08:53

two diabetics culture works very

play08:56

effectively to reduce inflammation

play08:59

in the cells of your pulm

play09:02

veins the blood vessel cells that over

play09:06

time will modify and become electrified

play09:09

those cells in your pulmonary veins can

play09:11

become

play09:12

electrified and have an electrical

play09:15

signal when they shouldn't have a signal

play09:16

that interferes with the normal

play09:18

signaling of the electrical system of

play09:20

the heart and we call that atrial

play09:22

fibrillation and ccine also reduces

play09:26

inflammation in those cells and reduces

play09:28

the the abnormal electrification of the

play09:31

heart and has an anti- atrial

play09:33

fibrillation

play09:35

effect so the combination and and to how

play09:39

where exactly does culine

play09:41

work well cusine specifically reduces

play09:46

activation of white blood cells of

play09:49

lucites decreases their activation

play09:52

decreases their aggressive function and

play09:55

decreases their adhesion

play10:00

to plaque and if you remember plaque

play10:02

starts out with a fibrin clot adding

play10:05

platelets aspirin blocks that and then

play10:09

the activated platelets bring white

play10:10

cells in and the white cells bring

play10:11

macrofagos in and The macras Bu bring

play10:14

pla in or lipids so if you use an

play10:17

aspirin to block platelets and you use

play10:20

culturein to reduce that effective the

play10:23

the inflam inflammation and the

play10:25

activation of those white cells and the

play10:27

adherence of those white cells you are

play10:28

doing two massive things to reduce clot

play10:32

propagation while not interfering with

play10:36

the clot itself because there are things

play10:39

like eloquest that are factor 10A

play10:41

Inhibitors that prevent the clot well if

play10:43

I cut myself I want a clot and yes

play10:46

ideally I want activated plates I want

play10:48

activated white cells but if there's a

play10:50

balance between reducing a cut from a

play10:53

clot uh from uh the clotting from a cut

play10:56

and reducing pla formation if I'm at

play10:58

risk for pla formation

play11:00

this is where that balance Works where I

play11:02

can still clot off a or at least create

play11:04

an early clot for a a cut which is a

play11:07

onetime event but I'm not having this

play11:10

ongoing massive anti-inflammatory

play11:12

response excessive anti-inflammatory

play11:15

response occurring in my blood vessels

play11:17

that is going to kill me of a heart

play11:18

attack or a stroke there's no right

play11:19

answer it's not absolute but that is

play11:21

what we do with people that already have

play11:24

inflammatory disease so the baby aspirin

play11:26

shouldn't be taken by someone who's got

play11:27

no risk or low risk same with the

play11:29

culture scene but if your uric acid is

play11:32

high if you're a PL inflammatory and

play11:34

you've got plaa you've had an event the

play11:36

combination of ASP and culture scene is

play11:38

highly recommended particularly as a

play11:41

weapon against Statin so stop the Statin

play11:43

and take those two

play11:45

meds just be very aware of the dosing

play11:48

and low dosing is the way to

play11:50

go so culture scene interferes with

play11:54

white cell adhesion white cell function

play11:56

and it also reduces the inflamm romes

play12:00

that put out all these pro-inflammatory

play12:01

cyto kindes so it reduces the

play12:04

inflammatory uh risk and so many people

play12:06

with cardiovascular disease aeroic

play12:08

cardiovascular disease have high uric

play12:10

acid

play12:11

levels high uric acid levels and we see

play12:13

that even our in our Alam HRS so there's

play12:16

that double

play12:18

benefit so I become very very gung-ho on

play12:22

on culture scene albeit my primary focus

play12:25

is to reduce inflammation so I don't

play12:27

need any of those drugs but if you

play12:29

already have the disease and you don't

play12:30

want to see

play12:32

propagation this may be a better added

play12:36

strategy definitely in my opinion the

play12:38

baby aspirin and then under certain

play12:41

circumstances the addition of culture SE

play12:44

so example I had a patient couple of

play12:46

weeks ago taking his baby aspirin but he

play12:49

has a huge burden I think it was 36 or

play12:52

3,700 um C score and also a burden of

play12:56

pluck in all of his vessels in the cored

play12:58

in the ver

play13:00

uh and he had a small stroke on

play13:04

aspirin disease everywhere and developed

play13:07

a small clot in the Basler artery of his

play13:10

brain well

play13:12

perhaps if he was on culture scene as

play13:15

well as aspirin that may not have

play13:16

happened now the good news is they got

play13:18

to him early they removed that clot and

play13:19

he's got very little residual effect of

play13:21

that stroke but it could have been

play13:22

catastrophic and if he wasn't on the

play13:24

aspirin he probably would have

play13:26

died or had death of his brain

play13:30

but I'd like to put him or suggest to

play13:33

him I never put anybody on suggest to

play13:35

him that we add culture scene to the mix

play13:38

now he's also doing a wonderful job of

play13:40

reducing ongoing

play13:44

inflammation reducing ongoing

play13:46

inflammation through dietary changes

play13:47

through Lifestyle Changes which is the

play13:50

foundation but because he's got existing

play13:53

disease because he had a

play13:54

life-threatening event the risk or the

play13:56

downside of culture scene any downside

play13:59

which is really from toxicity is far

play14:01

more worth accepting for the massive

play14:05

benefit so that's the way my brain works

play14:08

and I'm not going to he says no I'm fine

play14:10

with that it's a decision we make but in

play14:12

order to say yes or no you need the

play14:14

knowledge and you need the science not

play14:16

the emotive thinking I'm not going to

play14:18

scare him I'm just going to say hey this

play14:20

is something we've learned this is

play14:21

something you can add to it now this

play14:24

from David neighbor so this is a

play14:27

cardiologist's use of this medic a and

play14:29

in his population he sees a lot of

play14:31

people that are not willing to go on a

play14:33

on a low carbohydrate diet my population

play14:36

are all at least trying and if you're

play14:37

trying but struggling or if you say

play14:40

screw it well screw it doesn't is not

play14:41

going to fix the problem but what David

play14:44

talks about is when he sees a CRP and we

play14:46

test CRP on everybody above two and you

play14:49

have pre-existing cardiovascular disease

play14:52

he uses A5 MGR dose now for gout we use

play14:56

a 6 Mig dose a day and that that cost

play14:59

you about $20 a month through something

play15:01

like good

play15:02

RX about $32 at CVS for a 90day supply

play15:07

so it's not expensive just like baby

play15:09

aspin is not expensive statins are far

play15:11

more expensive although they may be

play15:12

covered by insurance

play15:15

so um if you have if you meet the

play15:18

criteria secondary prevention

play15:20

significant plaque burden elevated CRP

play15:24

then adding culture scene to your

play15:25

aspirin and ask me about it if you're a

play15:27

patient of mine maybe a very effective

play15:30

safe non-toxic non-harmful way to go

play15:34

because of the stattin profile of harm

play15:36

and less

play15:37

Effectiveness and under these

play15:41

conditions you can even go to lower

play15:44

dosing so as your CRP improves you can

play15:47

go down to taking half a tablet 2.5 migr

play15:51

every day or maybe even doing it Monday

play15:54

Wednesday Friday because the benefits

play15:56

occur at a very low dose

play15:59

so that's David's strategy I found that

play16:02

half a tablet on weekend strategy works

play16:04

pretty well in people who struggle with

play16:07

compliance or people who uh um do not

play16:10

have a very high CRP but have a high

play16:12

plaque

play16:15

burden so I think the the

play16:21

value of preventing clot in a safe way

play16:26

where we know it's

play16:27

effective it has value in people with

play16:30

pre-existing disease but if you've got a

play16:31

zero CC score like me don't even go down

play16:33

that pathway but work really hard on

play16:36

preventing inflammation not smoking not

play16:39

having insulin

play16:41

resistance and that's where the gp1s and

play16:44

some of the diabetic medications may

play16:46

have greater Advantage but you need to

play16:48

know about culture scene you need to

play16:50

know about its effect you need to ask

play16:52

those questions and the final thing I'll

play16:55

tell you this is the paper the paper

play16:59

published in the journal uh the Journal

play17:01

of the American College of Cardiology

play17:03

says lowd dose culture seen for

play17:05

secondary prevention of carony artery

play17:07

disease and I'll give you the

play17:10

summary inflammation assessed by means

play17:13

of Highly sensitivity CRP

play17:16

hscp is a more powerful determinant of

play17:20

cardiovascular Death and All cause

play17:23

mortality than low density lipoprotein

play17:26

ldlc

play17:30

so hscrp a mark of inflammation is more

play17:34

predictive of cardiovascular death than

play17:37

LDL which is what every cardiologist is

play17:39

measuring all the time that's their

play17:42

starting point and these are

play17:43

cardiologists several therapies that

play17:45

Target residual

play17:47

inflammation residual inflammatory risk

play17:50

significantly reduce vascular event

play17:53

rates for coron artery disease patients

play17:57

already taking

play17:59

other medications including statins lowd

play18:03

dose culture scene and I'm going to

play18:05

paraphrase here may be a very healthy

play18:08

very effective and this is coming from

play18:10

me Robert cus not them because they use

play18:12

it on top of a Statin a very very

play18:14

healthy alternative to a Statin and the

play18:17

low dose is .5 Mig Orly and this has

play18:21

been shown to safely lower major adverse

play18:26

cardiovascular Risk by 31% % amongst

play18:30

those with stable atherosclerotic

play18:32

disease and

play18:34

23% secondary reduction if you've had a

play18:38

heart attack so if you've had a heart

play18:39

attack your risk of a second heart

play18:41

attack is lowered by 23% basically one

play18:44

quarter reduction on culture scene

play18:46

without any other changes you then

play18:47

change your diet and you massively

play18:49

reduce

play18:50

that these magnitudes are magnitudes of

play18:54

benefit are

play18:55

larger than those seen with lipid

play18:58

lowering

play18:59

agents lipid lowering and inflammatory

play19:02

Inhibitors are not in Conflict but are

play19:05

synergistic and I disagree with that I

play19:07

disagree with that

play19:09

statement that's where they and I

play19:11

disagree culture scene is a replacement

play19:14

for stattin not to be used with a

play19:16

stattin in my opinion but in June of

play19:18

2023 exactly a year ago the US Food and

play19:22

Drug Administration the FDA approved the

play19:25

use of lowdose culture scene to reduce

play19:27

the risk of myocard fuction stroke Cal

play19:30

rasul and cardiovascular death in

play19:34

patients with established atic disease

play19:37

or multiple risk factors for

play19:40

cardiovascular disease

play19:42

including atrial

play19:46

fibrillation

play19:49

H it's in the College of Cardiology they

play19:52

don't talk about

play19:53

it because it doesn't fit their

play19:56

narrative that inflammation is the

play19:57

problem not lipids

play19:59

if I've made you think if I've given you

play20:02

new knowledge and I know I have I've

play20:05

done my job leave a dollar in our PayPal

play20:09

account till next time

Rate This

5.0 / 5 (0 votes)

Ähnliche Tags
Cardiovascular HealthAnti-InflammatoryStatin AlternativeColchicine BenefitsInflammation ManagementHeart DiseaseGout TreatmentCRP LevelsSecondary PreventionHealth Education
Benötigen Sie eine Zusammenfassung auf Englisch?